Immune to Cancer: The CRI Blog
-
2022 International Cancer Immunotherapy Conference Highlights from Day 1
Back for the first time since the COVID-19 pandemic began, the sixth annual CRI-ENCI-AACR International Cancer Immunotherapy… -
The Many Fates of T Cells with CRI Lloyd J. Old STAR Enrico Lugli, PhD
CRI Lloyd J. Old STAR Enrico Lugli, PhD, is deciphering why some T cells have longevity and…
-
Improving Cell Therapies by Characterizing Our Immune Arsenal with CRI STAR Dr. Ning Jenny Jiang
Dr. Ning Jenny Jiang, a CRI Lloyd J. Old STAR at the University of Pennsylvania, is working to…
-
AACR21 Recap: CRI Scientists Highlight the Latest in ‘Discovery Science Driving Clinical Breakthroughs’
During AACR21, CRI scientists highlighted how improving our understanding of basic immune biology may enable improved immunotherapies…
-
CRI Speaks with 2021 Lloyd J. Old Award Recipient Dr. Ton Schumacher
Dr. Ton Schumacher, 2021 Lloyd J. Old Award recipient, discusses his career accomplishments and the future of…
-
Meet Dr. Andrea Schietinger, One of Our New Lloyd J. Old STAR Scientists
Zooming into the tumor and following cell populations over time throughout tumor development or therapeutic response with…
-
Meet Dr. Alexander Marson, One of CRI’s New Lloyd J. Old STARs
We spoke with Dr. Alexander Marson to learn more about his work and what he hopes to…
-
30 Days of CRI Impact
Throughout Cancer Immunotherapy Month in June we’ll be highlighting the 30 most important CRI-funded breakthroughs.